Epidermolysis bullosa: from fundamental molecular biology to clinical therapies.
Featherstone
Carol
C
c.featherstone@wanadoo.fr
D002294:Carcinoma, Squamous Cell / Q000209:etiology; D004820:Epidermolysis Bullosa / Q000150:complications / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D005347:Fibroblasts / Q000637:transplantation; D015316:Genetic Therapy; D006801:Humans; D008967:Molecular Biology; D010447:Peptide Hydrolases / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000209:etiology; D053782:Transforming Growth Factor beta3 / Q000627:therapeutic use; D014945:Wound Healing / Q000187:drug effects
D053782:Transforming Growth Factor beta3; D010447:Peptide Hydrolases